Dan R Robinson Selected Research

Dan R Robinson Research Topics

Disease

23	Neoplasms (Cancer) 04/2021 - 11/2011
12	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2004
6	Breast Neoplasms (Breast Cancer) 12/2021 - 11/2011
3	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2014
2	Leukemia 02/2020 - 01/2018
2	Carcinogenesis 01/2019 - 09/2015
1	Carcinoma (Carcinomatosis) 04/2021
1	COVID-19 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Actinic Keratosis 11/2020
1	Carcinoma in Situ 11/2020
1	Squamous Cell Carcinoma of Head and Neck 06/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2020
1	Melanoma (Melanoma, Malignant) 12/2019
1	Residual Neoplasm 12/2019
1	Circulating Neoplastic Cells 01/2018
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2018
1	Brain Neoplasms (Brain Tumor) 10/2017
1	Disease Progression 01/2017
1	Retinoblastoma (Glioblastoma, Retinal) 09/2015
1	Lung Neoplasms (Lung Cancer) 12/2014
1	Mouth Neoplasms (Oral Cancer) 06/2013
1	Glioblastoma (Glioblastoma Multiforme) 06/2013
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Thyroid Neoplasms (Thyroid Cancer) 06/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2013
1	Colorectal Neoplasms (Colorectal Cancer) 11/2011

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 04/2021 - 11/2011
6	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 11/2011
5	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 11/2011
4	AndrogensIBA 01/2021 - 07/2012
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2011
4	Phosphotransferases (Kinase)IBA 06/2013 - 10/2004
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2013
3	Hormones (Hormone)IBA 01/2021 - 12/2013
2	Estrogen ReceptorsIBA 01/2021 - 12/2013
2	ChromatinIBA 01/2019 - 07/2012
2	Long Noncoding RNAIBA 03/2015 - 08/2014
1	Estrogen Receptor alphaIBA 12/2021
1	LigandsIBA 12/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Serine Proteases (Serine Protease)IBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	palbociclibIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Cyclin DIBA 01/2021
1	tetrachloroisophthalonitrile (Bravo)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 11/2020
1	ParaffinIBA 11/2020
1	Fibronectins (Fibronectin)IBA 06/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019
1	Mitogen-Activated Protein KinasesIBA 12/2019
1	UbiquitinIBA 12/2019
1	trametinibIBA 12/2019
1	dabrafenibIBA 12/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Circular RNAIBA 01/2019
1	ElementsIBA 01/2019
1	Cytochrome P-450 CYP3AIBA 01/2018
1	Cytochrome P-450 CYP2C19IBA 01/2018
1	Pharmaceutical PreparationsIBA 10/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	olaparibIBA 01/2017
1	PlatinumIBA 01/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	Tumor Viral Antigens (Large T Antigen)IBA 09/2015
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 09/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2014
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2014
1	BI 6727IBA 03/2013
1	Protein Kinases (Protein Kinase)IBA 03/2013
1	Polo-like KinasesIBA 03/2013
1	Histones (Histone)IBA 07/2012
1	Competitive Endogenous RNAIBA 06/2012
1	Aurora Kinase AIBA 11/2011
1	Cyclin-Dependent Kinase 8IBA 11/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2004
1	ChemokinesIBA 10/2004

Therapy/Procedure

14	Therapeutics 12/2021 - 11/2011
6	Castration 01/2022 - 07/2012
4	Precision Medicine 12/2021 - 09/2015
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 12/2019